The role of extracellular vesicles in physiological and pathological conditions (literature review)
DOI:
https://doi.org/10.15574/PP.2024.97.97Keywords:
extracellular vesicles, exosomes, multivesicular bodies, micro-RNA, biomarkersAbstract
The article presents a review of medical literature on the current views on the role of extracellular vesicle ribonucleic acid (RNA) in physiological and pathological conditions.
Purpose - to highlight the current scientific knowledge about the importance of extracellular vesicles in physiological and pathological conditions, new possibilities for diagnosis and treatment.
Extracellular vesicles, in particular exosomes, have experienced a revival of interest following studies indicating their importance in numerous events of intercellular interaction. The main attention is paid to the studies that investigated the pathophysiology of microvesicles and exosomes in normal and most common diseases, diagnostic features and possibilities of application in clinical practice. In the area of reproductive medicine, there is a growing interest in understanding the role of extracellular vesicles in the male and female reproductive system, as they may represent a new mechanism of communication between the reproductive tract and immature germ cells or between the mother and fetus. This could potentially have a significant impact on the understanding of pregnancy-related processes and the development of complications. Their usefulness as biomarkers of pathological conditions such as preeclampsia, spontaneous preterm labor, and polycystic ovary syndrome is being studied.
Conclusions. The relationship between exosomal microRNAs and various diseases has been summarised. However, the use of exosomes has limitations due to technical and economic reasons. The purity of the isolated exosomes needs to be improved, which requires better technologies and equipment. The role of exosomal microRNAs in living organisms is highlighted, their value and potential use in terms of the source and mechanism of action of exosomes are demonstrated. More exosomal therapeutic agents will be used in future clinical trials, which gives hope for the emergence of new methods of diagnosis and treatment of many diseases.
No conflict of interests was declared by the authors.
References
Ashley J, Cordy B, Lucia D et al. (2018). Retrovirus-like gag protein Arc1 binds RNA and traffics across synaptic boutons. Cell. 172 (1-2): 262-274.e211. https://doi.org/10.1016/j.cell.2017.12.022; PMid:29328915 PMCid:PMC5793882
Barraclough JY, Joan M, Joglekar MV, Hardikar AA, Patel S. (2019). MicroRNAs as Prognostic Markers in Acute Coronary Syndrome Patients-A Systematic Review. Cells. 8(12): 1572. https://doi.org/10.3390/cells8121572; PMid:31817254 PMCid:PMC6952952
Budnik V, Ruiz-Cañada C, Wendler F. (2016). Extracellular vesicles round off communication in the nervous system. Nat. Rev. Neurosci. 17(3): 160-172. https://doi.org/10.1038/nrn.2015.29; PMid:26891626 PMCid:PMC4989863
Davidson SM, Boulanger CM, Aikawa E et al. (2023, Mar 17). Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles. Cardiovasc Res. 119(1): 45-63. https://doi.org/10.1093/cvr/cvac031; PMid:35325061 PMCid:PMC10233250
Fitzner D, Schnaars M, Van Rossum D, Krishnamoorthy G, Dibaj P, Bakhti M et al. (2011). Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci. 124; Pt 3: 447-458. https://doi.org/10.1242/jcs.074088; PMid:21242314
French KC, Antonyak MA, Cerione RA. (2017). Extracellular vesicle docking at the cellular port: extracellular vesicle binding and uptake. Semin Cell Dev Biol. 67: 48-55. https://doi.org/10.1016/j.semcdb.2017.01.002; PMid:28104520 PMCid:PMC5484727
Gege L, Jun W, Guo C et al. (2022). The potential therapeutic value and application prospect of engineered exosomes in human diseases. Front cell Dev Biol. 10: 1051380. https://doi.org/10.3389/fcell.2022.1051380; PMid:36531952 PMCid:PMC9751586
Gurunathan S, Kang MH, Jeyaraj M et al. (2019). Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. Cells. 8(4): 307. https://doi.org/10.3390/cells8040307; PMid:30987213 PMCid:PMC6523673
Hessvik NP, Lorente L. (2018). A current knowledge on exosome biogenesis and release. cell Mol life Sci. 75(2): 193-208. https://doi.org/10.1007/s00018-017-2595-9; PMid:28733901 PMCid:PMC5756260
Hu W, Liu C, Bi ZY, Zhou Q, Zhang H, Li LL et al. (2020, Jun 5). Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology. Mol Cancer. 19(1): 102. https://doi.org/10.1186/s12943-020-01199-1; PMid:32503543 PMCid:PMC7273667
Kalluri R, LeBleu VS. (2020). The biology, function, and biomedical applications of exosomes. Science. 367(6478): eaau6977. https://doi.org/10.1126/science.aau6977; PMid:32029601 PMCid:PMC7717626
Lasser С. (2019). Mapping extracellular RNA sheds lights on distinct carriers. cell. 177(2): 228-230. https://doi.org/10.1016/j.cell.2019.03.027; PMid:30951666
Li S, Lv D, Yang H, Lu Y, Jia Y. (2023, Dec). A review on the current literature regarding the value of exosome miRNAs in various diseases. Ann Med. 55(1): 2232993. https://doi.org/10.1080/07853890.2023.2232993; PMid:37435923 PMCid:PMC10339768
Murillo D, Thistlethwaite W, Rozowsky J et al. (2019). A exRNA atlas analysis reveals distinct extracellular RNA cargo types and their carriers present across human biofluids. cell. 177(2): 463-477.e15. https://doi.org/10.1016/j.cell.2019.02.018; PMid:30951672 PMCid:PMC6616370
Paolillo M, Schinelli S. (2017). Integrins and exosomes, a dangerous liaison in cancer progression. Cancers (Basel). 9(8): E95. https://doi.org/10.3390/cancers9080095; PMid:28933725 PMCid:PMC5575598
Pathan M, Pamali F, Sai C et al. (2019). Yesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res. 47(D1): D516-D519. https://doi.org/10.1093/nar/gky1029; PMid:30395310 PMCid:PMC6323905
Qing M, Xiao W, Jing Z et al. (2018). Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365. Exp. cell Res. 362(2): 386-393. https://doi.org/10.1016/j.yexcr.2017.12.001; PMid:29223442
Ridder K, Sevko A, Heide J, Dams M, Rupp AK, Macas J et al. (2015). Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment. OncoImmunology. 4(6): e1008371. https://doi.org/10.1080/2162402X.2015.1008371; PMid:26155418 PMCid:PMC4485784
Rutter BD, Innes RW. (2017, Jan). Extracellular Vesicles Isolated from the Leaf Apoplast Carry Stress-Response Proteins. Plant Physiol. 173(1): 728-741. https://doi.org/10.1104/pp.16.01253; PMid:27837092 PMCid:PMC5210723
Selvaraj J, Dhanavathy G, Johnson R et al. (2021). Stem cell-derived exosomes potential therapeutic roles in cardiovascular diseases. Front cardiovasc Med. 8: 723236. https://doi.org/10.3389/fcvm.2021.723236; PMid:34447796 PMCid:PMC8382889
Shahrzad N, Sara S, Ardeshir H et al. (2018). Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes. J cell Biochem. 119(11): 9433-9443. https://doi.org/10.1002/jcb.27260; PMid:30074271
Simon C, Greening DW, Bolumar D, Balaguer N, Salamonsen LA, Vilella F. (2018, Jun 1). Extracellular Vesicles in Human Reproduction in Health and Disease. Endocr Rev. 39(3): 292-332. https://doi.org/10.1210/er.2017-00229; PMid:29390102
Stahl D, Raposo G. (2019, May 1). Extracellular vesicles: exosomes and microvesicles, integrators of homeostasis. Physiology (Bethesda). 34(3): 169-177. https://doi.org/10.1152/physiol.00045.2018 PMid:30968753
Stephanie P, Amy B, Mark H et al. (2019). Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosis. Cell Mol life Sci. 76(6): 1093-1106. https://doi.org/10.1007/s00018-018-2983-9; PMid:30569278
Théry C, Witwer KW, Aikawa E et al. (2018, Nov 23). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 7(1): 1535750.
Wang W, Han Y, Jo HA et al. (2020). Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenviroment. J Hematol oncol. 13(1): 67. https://doi.org/10.1186/s13045-020-00893-3; PMid:32503591 PMCid:PMC7275461
Xian W, Yi T, Zhao L et al. (2021). The application potential and advance of mesenchymal stem cell-derived exosomes in myocardial infarction. Stem cells int: 5579904. https://doi.org/10.1155/2021/5579904; PMid:34122557 PMCid:PMC8189813
Xu C, Qi L. (2022). Potential clinical applications of exosomes in the diagnosis, treatment, and prognosis of cardiovascular diseases: a narrative review. Ann transl Med. 10(6): 372. https://doi.org/10.21037/atm-22-619; PMid:35433929 PMCid:PMC9011294
Yong S, Youngeun K, Sun H et al. (2021). The emerging role of exosomes as novel therapeutics: biology, technologies, clinical applications, and the next. Am J Reprod. immunol. 85(2): e13329. https://doi.org/10.1111/aji.13329; PMid:32846024 PMCid:PMC7900947
Zaborowski MP, Balaj L, Breakefield XO, Lai CP. (2015). Extracellular vesicles: composition, biological relevance, and methods of study. Bioscience. 65(8): 783-797. https://doi.org/10.1093/biosci/biv084; PMid:26955082 PMCid:PMC4776721
Zhong W, Zeng W, Hai X et al. (2022). Exosomal noncoding RNAs in central nervous system diseases: biological functions and potential clinical applications. Front Mol Neurosci. 15: 1004221. https://doi.org/10.3389/fnmol.2022.1004221; PMid:36438184 PMCid:PMC9681831
Zomer A, Maynard C, Verweij FJ, Kamermans A, Schafer R, Beerling E et al. (2015). In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell. 161(5): 1046-1057. https://doi.org/10.1016/j.cell.2015.04.042; PMid:26000481 PMCid:PMC4448148
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ukrainian Journal of Perinatology and Pediatrics
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “Ukrainian Journal of Perinatology and Pediatrics” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license(СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
